Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06978 IMMUNOTECH-B
RT Nominal up2.400 +0.060 (+2.564%)
Shareholder's Disclosure of Interests
Disclosure of Interest   ｜   Fund Raising   ｜   Share Repurchase
Date Shareholder name Reason of Disclosure Buy/Sell and
Involved Shares		 Average Price per share Current Holdings % of Issued Shares
04/08/20241711(L)+165,595,721(L)165,595,721(L)32.18
04/08/2024China Resources Company Limited1711(L)+165,595,721(L)217,054,121(L)42.18
04/08/2024China Resources Pharmaceutical Group Limited1711(L)+165,595,721(L)217,054,121(L)42.18
11/04/2023Jung Hyun Chul1304(S)-90,128,571(S)44,820,000(L)8.71
11/04/2023Evodevo LTD1304(S)-90,128,571(S)44,820,000(L)8.71
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/2023Yan Xijun1303(L)90,128,571(L)191,595,721(L)37.23
31/03/2023Yan Kaijing1303(L)90,128,571(L)191,595,721(L)37.23
31/03/2023Li Yunhui1303(L)90,128,571(L)191,595,721(L)37.23
31/03/2023Wu Naifeng1303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/2023Tasly (Hong Kong) Pharmaceutical Investment Limited1303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
31/03/20231303(L)90,128,571(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/2023Li Yunhui1205(L)-51,480,000(L)191,595,721(L)37.23
20/02/2023Wu Naifeng1205(L)-51,480,000(L)191,595,721(L)37.23
20/02/2023Yan Xijun1205(L)-51,480,000(L)191,595,721(L)37.23
20/02/2023Tan Yueyue1316(L)6,714,286(L)59,794,286(L)11.62
20/02/20231205(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
20/02/2023Yan Kaijing1205(L)-51,480,000(L)191,595,721(L)37.23
20/02/2023Tasly (Hong Kong) Pharmaceutical Investment Limited1205(L)-51,480,000(L)191,595,721(L)37.23
20/02/20231205(L)-51,480,000(L)191,595,721(L)37.23
 1   2  
Remark: (L) - Long Position, (S) - Short Position, (P) Lending;
  Real time quote last updated: 23/12/2024 15:39
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.